Skip to main content
Skip to navigation

Teva Facing Probe for Potential False Claims Act Violations

By Jaclyn Jaeger2014-02-11T12:16:00

THIS IS MEMBERS-ONLY CONTENT

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.

Related articles

Article
Teva to pay $54M in FCA whistleblower settlement

2020-01-07T20:01:00Z By Jaclyn Jaeger

Teva Pharmaceuticals has reached a $54 million settlement in a lawsuit filed by two whistleblowers over allegations the drug company bribed physicians through numerous “sham” speaker programs in exchange for prescribing Teva drugs.
News Brief
FTC complaint accuses LA Fitness parent companies of blocking easy membership exits

2025-08-21T18:58:00Z By Oscar Gonzalez

The Federal Trade Commission filed a complaint against LA Fitness’ parent companies, citing difficulties canceling memberships, a month after a court blocked the agency’s click-to-cancel rule.
Article
Judge orders CVS to pay nearly $290M for Medicare false claims

2025-08-20T21:22:00Z By Adrianne Appel

CVS’s Caremark division knowingly overcharged Medicare for prescription drugs and must pay nearly $290 million, a Pennsylvania federal judge has ordered.